STAT+: Pharmalittle: We’re reading about TrumpRx prices, a J&J psoriasis pill, and much more
Stat News • 3/13/2026 – 3/18/2026
Summary
No summary yet.
Advertisement
Cluster Activity
2
1
2026-03-132026-03-18
Lindy Score Breakdown (V4.2)
5h
Age
1
Sources
from cluster
4
Hours Since Seen
Final Score12/100
CategoryAntiLindy
StatusActive
Recency Multiplier94% (0.5^4/48)
Hero EligibleYes
Story Timeline
- 2026-03-13
- 2026-03-18STAT+: Pharmalittle: We’re reading about TrumpRx prices, a J&J psoriasis pill, and much more (current)
Score BreakdownRisk 70
Source Reputation: Low-trust source (4/20 pts)
Consensus: Single source - no independent confirmation yet
Age: Breaking news - too recent to assess longevity
Stories gain Lindy status through source reputation, network consensus, and time survival.
Same Story from 3 sources
Breaking Similar stories
STAT+: Pharmalittle: We’re reading about obesity pill trial results, cholesterol guidelines, and more
Stat News • 2 days ago
STAT+: Pharmalittle: We’re reading about Trump’s drug pricing moves, a GSK asthma drug, and more
Stat News • 1 day ago
STAT+: J&J wins approval for first-of-its-kind psoriasis pill
Stat News • Today
STAT+: Structure Therapeutics reports significant weight loss from mid-stage GLP-1 pill
Stat News • 2 days ago
STAT+: Two more drugmakers join TrumpRx
Stat News • 2 days ago
STAT+: Clearing tumors in mice, Azalea Therapeutics advances dream of in vivo CAR-T therapy
Stat News • Today
STAT+: A Huntington’s researcher on the UniQure-FDA fray
Stat News • Today
STAT+: How a Texas couple is getting rich off out-of-network medical bills
Stat News • Today
STAT+: For decades, they’ve set the record straight in biology. Next up: science’s reproducibility crisis
Stat News • 1 day ago
STAT+: NIH will spend its full budget this year, agency director promises House appropriators
Stat News • 1 day ago